文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

加拿大ICU中的加速死亡:医疗辅助死亡时代的终末期照护

Hastening Death in Canadian ICUs: End-of-Life Care in the Era of Medical Assistance in Dying.
PubMed 文献 · Crit Care Med · 2021-10-04
一句话结论多数加拿大重症医生认为医疗辅助死亡未改变其撤除生命维持治疗的方式,但近半数认为在预期死亡时有意加速死亡符合伦理。

该研究通过电子问卷调查了加拿大11个儿科和14个成人ICU项目的重症医生及学员,共获得150份完整问卷(应答率33%),其中50%为成人从业者、81%来自学术中心。86%熟悉医疗辅助死亡立法,71%支持,14%内心矛盾,11%反对;仅5%认为立法影响了其撤除生命维持治疗的方式。半数所在单元无标准化撤除流程,41%曾观察到撤除时药物剂量不成比例偏高,13%曾亲自给药;80%经历过家属明确要求加速死亡,47%认为在预期死亡时有意加速死亡符合伦理。结论提示多数医生实践未变,但相当少数存在伦理冲突。

要点

  • 150名加拿大重症医生中仅5%(n=8)认为医疗辅助死亡立法改变了其撤除生命维持治疗的方式。
  • 80%(n=120)曾经历家属明确要求加速死亡,47%(n=70)认为撤除后有意加速死亡符合伦理。
  • 41%(n=62)曾观察到撤除生命维持治疗时药物剂量不成比例偏高,13%曾亲自给予此类剂量。
  • 半数受访者所在ICU无标准化撤除生命维持治疗方案。
  • 71%支持医疗辅助死亡,14%内心矛盾,11%反对。

适用人群与场景

  • 加拿大11个儿科ICU项目和14个成人ICU项目的重症医生及重症监护学员,2019年12月至2020年5月在职者。
  • 81%(n=121)来自学术中心;50%为成人从业者,50%为儿科从业者。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 80%(n=120)曾经历家属明确要求加速死亡;47%(n=70)认为在预期死亡时有意加速死亡符合伦理。
  • 41%(n=62)曾观察到撤除生命维持治疗时药物剂量不成比例偏高,13%曾亲自给予此类剂量。
  • 半数受访者所在单元无标准化撤除生命维持治疗方案。

研究设计与关键结果

  • 研究类型:电子问卷调查;加拿大11个儿科ICU项目和14个成人ICU项目;150份完整问卷,应答率33%;50%成人从业者,81%学术中心。
  • 86%(n=130)熟悉医疗辅助死亡立法,71%支持,14%内心矛盾,11%反对。
  • 仅5%(n=8)认为医疗辅助死亡立法影响了其撤除生命维持治疗的方式。
  • 50%无标准化撤除生命维持治疗方案;41%(n=62)曾观察到撤除时药物剂量不成比例偏高,13%曾亲自给药。
  • 80%(n=120)曾经历家属明确要求加速死亡;47%(n=70)认为撤除后有意加速死亡符合伦理。

证据类型、等级与局限

  • 证据类型:电子问卷调查(横断面研究);采用雪球抽样,由科室负责人分发研究信息,所有回答匿名。
  • 局限:应答率33%,样本量150,雪球抽样非随机,可能影响代表性;原文未给出证据等级或推荐强度。

对床旁实践的改变

  • 多数受访加拿大重症医生认为医疗辅助死亡立法未改变其撤除生命维持治疗的方式,但近半数认为预期死亡时有意加速死亡符合伦理。
  • 41%曾观察到撤除生命维持治疗时药物剂量不成比例偏高,提示需关注撤除过程中药物使用的规范性与记录。
  • 半数ICU无标准化撤除生命维持治疗方案,提示可考虑建立标准化流程以减少实践差异。
  • 80%曾经历家属要求加速死亡,47%认为有意加速死亡符合伦理,提示团队需就伦理边界与沟通策略达成共识。

指南或共识出处

  • Crit Care Med

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Since 2016, Canada has allowed for euthanasia based on strict criteria under federal medical assistance in dying legislation. The purpose of this study was to determine how Canadian intensivists perceive medical assistance in dying and whether they believe their approach to withdrawal of life-sustaining therapies has changed following introduction of medical assistance in dying.

DESIGN: Electronic survey.

SETTING: Participants were recruited from 11 PICU programs and 14 adult ICU programs across Canada. All program leaders for whom contact information was available were approached for participation.

PARTICIPANTS: We invited intensivists and critical care trainees employed between December 2019 and May 2020 to participate using a snowball sampling technique in which department leaders distributed study information. All responses were anonymous. Quantitative data were analyzed using descriptive statistics. Categorical variables were analyzed using Pearson chi-square test.

INTERVENTIONS: Not applicable.

MEASUREMENTS AND MAIN RESULTS: We obtained 150 complete questionnaires (33% response rate), of which 50% were adult practitioners and 50% pediatric. Most were from academic centers (81%, n = 121). Of respondents, 86% (n = 130) were familiar with medical assistance in dying legislation, 71% in favor, 14% conflicted, and 11% opposed. Only 5% (n = 8) thought it had influenced their approach to withdrawal of life-sustaining therapies. Half of participants had no standardized protocol for withdrawal of life-sustaining therapies in their unit, and 41% (n = 62) had observed medications given in disproportionately high doses during withdrawal of life-sustaining therapies, with 13% having personally administered such doses. Most (80%, n = 120) had experienced explicit requests from families to hasten death, and almost half (47%, n = 70) believed it was ethically permissible to intentionally hasten death following withdrawal of life-sustaining therapies.

CONCLUSIONS: Most Canadian intensivists surveyed do not think that medical assistance in dying has changed their approach to end of life in the ICU. A significant minority are ethically conflicted about the current approach to assisted dying/euthanasia in Canada. Almost half believe it is ethical to intentionally hasten death during withdrawal of life-sustaining therapies if death is expected.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Andersen SK, Stewart S, Leier B, et al. Hastening Death in Canadian ICUs: End-of-Life Care in the Era of Medical Assistance in Dying. Crit Care Med. 2021. PMID: 34605780. doi:10.1097/CCM.0000000000005359

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。